infiniwell bpc 157 with cognizin Michael Scanlon - Director of E-commerce Strategy @ BPC-157 Spray | Research-Grade Size:100 Grams (3.5 oz) research peptide blend

infiniwell bpc 157 with cognizin Michael Scanlon - Director of E-commerce Strategy @ BPC-157 Spray | Research-Grade Size:100 Grams (3.5 oz) research peptide blend

BPC-157 Spray | Research-Grade BPC 157 Peptide | Captide Labs

For more information, please contact us or request an appointment online

research peptide blend

Size:100 Grams (3.5 oz)

No toxicity observed in animal studies at therapeutic doses Phase I/II trials for inflammatory bowel disease in the 1990s reported safety with no toxicity The human knee injection study (16 patients) reported no adverse events A preliminary 2025 study administered intravenous BPC-157 to 2 participants with no adverse effects Injection site reactions (mild redness, temporary discomfort) – relatively common Occasional mild headache during initial use – uncommon Fatigue during first few days – rarely reported Vivid dreams – occasionally mentioned Effects on existing cancers due to angiogenic properties – theoretical but unproven Unknown effects of long-term use beyond several months Interactions with medications – not systematically studied Effects during pregnancy or lactation – no data available The angiogenesis promotion by BPC-157 raises theoretical questions about use in individuals with cancer history